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INTRODUCTION
The terms chronic non-congestive glaucoma, simple
glaucoma, and glaucoma �implex will all refer to the same
condition.
The consideration or the medical treatment of chronic
glaucoma should first emb race the meaning of the wo rd
glaucoma.

The name glaucoma designates any ocular condi

tion accompanied by an increase of intra.ocular pressure
to a point which causes damage to the visual apparatu8.
Tension above 29nnn.Hg� as measured by the Schiotg tono
meter is considered abnormally high while tension between
13 and 29mm.Hg. is considered normal.

It·must be recog

nized, however, that certain eyes will tolerate a tension
of 32 to 35mm.Hg. without detectable, evidence .o f damage
to function, while other eyes will show 0haracteristic
glaucomatous changes although the tensipn never rises
above 25mm. tension.

Glaucoma m:ay be divided into pri

mary and secondary types, while primart glaucoma is di;_
vided into its acute and chronic forms�

This thesis will

only consider the treatment of the chronic form or
primary glaucoma.

ETIOLOGY
The etiology of glaucoma simplex is not very well
understood.

Some of the theories are as follows:

(2)

1. an anatomic stu.rcture that will allow the cham
ber angle to become closed.
2. lack of tone of sympathetics that co ntrol ocular
vessels.
3. a sudden increase in blood pressure.
4. blood chemistry changes.

5. swelling of the vitreous.
6. low grade in fect ions.

7. age--rare under 35 years.
8. pigment in chamber angle.

CLINICAL PICTURE
1. Pain is entirely lacking in most cases.

There may

be dull aching but no severe pain.
2. Gradual loss of peripheral vision, usual ly not no
ticed until late in the disease.
3. Cupping of the optic disk.
first diagnosed.

Usually when glaucoma is

The border of the disk is involved in

at least one quadrant.
4. Pupil is moderately dilated and reacts to light and
accommodation, although somewhat sluggishly.
5. No congestion.
6. Visual changes show typical changes in every case.
This may be picked up before cupping of the disk or
abnormal elevation of tension.

The blind spot is en-

(3)

larged to form a sickle-shaped scotoma (Bjerrum's
scotoma), a sign: of compression of the nerve fibers at
the disk borders.

The peripheral field shows contraction

in one or more quadrants, usually nasal, giving �ise in
early cases to the so-called nasal step.
7. Varying increase in tension, usually around 35 to
40mm.(Schiotz).
8. The condition is nearly always bilateral.
9. Sex.
10. Age.
11. Shallow an.terior camber.

(4)

HISTORY
Over four centuries before the Christian era,
Hipp,9crates described glaukos as among the known affec
tions of the eye.

He used the Greek word glaukos to

describe the disease because he saw a gray-green reflex
from the pupil.

Literally the •.-.word means gleaming or

bluish-gray.
The Greeks and Latins who followed, spoke of those
causes giving rise to blindness and not aided by opera-

1

tion as glaucomata.
Helmholtz's discovery of the ophthalmoscope
aided in the detection o� chronic glaucoma.

in

1851

Adolph Weber

made the clinical discovery of the cupping of the disk.
Danders ro ·ted. that simple glaucoma. was but anothe;r form
of glaucoma unaccompanied by inf'lammatory symptoms.
MacKenzie in 1830 wrote that the daily use of
belladonna was beneficial to vision in glaucomatous
eyes.

Von Graefe later pointed out its harmful effects.
Laquer of Strasburg in 1876 introduced the use of

motics in the treatment of glaucoma.

Lebers proved

that intraocular fluid was secreted by the ciliary bo�y.
Watson (51) 1I?- 1872 recorded a case of chronic glau
coma in which an iridectomy was first done but complete
recovery ·was not obtain�d so liquori strychn1ae was given

(5)

three times a day and the patient's sight was improved.
However, the patient began having muscular twitchings of
his jaw, but since his sight was improving, the treatment
was continued with good results.
In 1878, a 75 year old woman presented herself to
Landesberg (33) and was diagnosed as chronic glaucoma.
The findings were·:

anterior ciliary vessels highly

distended ., cornea flat, of diminished sensibility and
l

occupied by punctiform exudations.
was almost obliterated.
dark-grayish color.
and immovable.

The anterior chamber

The iris was atrophic and of a

The pupil was dilated to the utmost

Tension was T2.

There w as deep excavation

of the optic disk which was surrounded by a broad atrophic
ring.

There was spontaneous arterial pulsation and

amaurosis.

The beginning of the affection was about 10

years ago.

She had been blind tor two years and did not

want an operation.

Therefore, one drop__ of eserine every

two hours was prescribed.

On the third day of treatment

the patient said she f.elt better and could sleep at night.
There was no. change in the intraocu.lar pressure or in
the excavation of. the optic disk.
one drop thr("e times.a day.

On the seventh da.y the intra

ocular pressure was hardly Tl.
one drop once a day.

The doctor then ordered

The doctor then ordered

Five months later the natient died

(6)

of consumption and in her last few days suffered inten�
paroxysms of pain and diminution of vis'ion j,_n the le:ft
eye.

The drops of eserine, which the patient had on

hand, had been used on these occasions and seemed to give
transitory relief', without preventing the.loss of sight.
Landesberg (33) summed up his results of the use of
eserine in chronic glaucoma.

He regarded eserine to be

not only unreliable ani in most cases a worthless remedy
in gl8;ucoma., but also a dangero·us one, which, by its pri

mary results, may lull the patient as well as the attend
ing physician into a delusive security, endangering
thus the favorable chances of another more efficacious
therapeutic agent.

He considered the eserine to be more

insidious in the hands of the patient.

The patient would

use the drug without reason in subsequent attacks and
would do himself more harm than good.
In 1881, Brailey in a discussion of Pye-Smith's (42)
cases, tho�ght that sulphate of eserine was of benefit
due to a hyperse<rretion into the vitreous chamber, the
outlets of the fluids of the eye remaining normal or being
only secondarily interfered.with by the increased pressure.
"Eserine relieves, not by any influence on the amount o't
secretion, but by re-establishing or even incre�sing
the normal out flow.

This it does, not by removing the

( 7.)

iris from contact with the entrances to Fontanna's
a.paces, for in ca s e s like these it is never found so
applied, by the influence of -the forcible contraction ot
all the muscular fibers of the ciliary body and iris
upon the ligamentmm pectinat:u.m, with which they are in
connection directly or indir�ctly.

By this means the

fibers constituting the mesh work leading to Schlemm' s
canal sre drawn inwards and separated from each other,
and a normal or even increased out flow is a' again per
mitted." {42}
Richey (43), in 1885 reported a case of chronic
simple glaucoma in a 37 year old woman.

The idea of

an operation created dread and tp.e treatment adopted
was sulphate of eserine applied twice a day, w1th dry
cups to the temples.

He believed that eserine not only

il1proved vision but arrested the progres� of: chronic
:simple glaucoma.

The frequency of applications of a

mild preparation lessened the tendency to spasmodic myo�
sis.

The action was more gentle and less likely to pro

duce congestion of either t�e conjunctiva or the iris.
Eserine was preferable to pilocarpine, because this
dispos � tion to s�- asm may be controlled, and it maintained
myosis for a longer_ perio d.
In 1887 1 Sargent (44) reported that the use of

{8)

5% cocaine solution instilled in the eye reduced the
tension and relieved the pain of glaucoma simplex.

The

cocaine produced some dizziness and hallucinations.
Sargent (44) stated that on future cases she would use
weaker solutions of cocaine.
In 1888, Coggin (7) of Salem, Mass. treated a 63
year old male with potassium bromide, strycbnia, and
acid phosphate and told him to return if any . paill. or
diminution of vision should appear in his eyes.

Two

months later he came back practically blind in the left
eye and at times it was very painful.
relieved by eserine solution but vision

This pain was
WPS

not im

proved •.
Sutphen {47) reported that in 1894 a patient came
to him with a gl�ucomatous eye which he diagnosed as
chronic glaucoma and for which all other remedies had
been tried with no benefit.

Sutphen {47) prescribed

salicylate of soda which brought quick relief and the
eye saved trom. enu!(e'ation.
He reported another case of a 50 year old male who
had suffered trauma to his left eye .followed by a complete
loss of vision and increased intraocular pressure.
a few days some pain was noted.

In

Under the administration

of salicylate of soda. gr.XV given internally and warm, wet
cloths applied locally, the eye was decidedly relieved

(9}

in two or three days and in a weeks time the patient was
�ble to resume his duties.

The eye gave the patient no

trouble since then.
Another patient previously treated with eserine and
morphine which did not relieve his pain was given only
sodium salicylate gr.XV every four hours and fomentation
applied locally to the eye.

The pain waa greatly relieved

the next day and disappeared in four days •.

The tension

was also greatly reduced.
Bower (4),

of London in 1900 reported that the ear ly

use of eserine and cocaine was of distinct benefit in

simple glaucoma especially when the tension was noted
early.
Cross (9) also of London, warned th& medical profession
that glaucom a must be differentiated from iritis or other
types of inflammatory eye diseases, especially before
starting treatm,ent with atropine and mydriatics which
tend to increase intraocular pressure.
Chronic glaucoma may be associated w ith a distinct
increase in eyeball tension on a degree that is imper
ceptible.

Cross (9) .said that sane cases of chronic

glaucoma :·1ay be cured by the use of' myotics, under com
fortable surroundings, and w ith avoidance of worry and
plenty of rest.

In one of his cases, Cross (9� gave

eserine gr. 1/6 which relieved the discomfort.

(10)

In another of his cases, he gave a woman pilo
carpine drops for eight years with relief from discomfort
and pain.

Another patient had received pilocarpine drops

for six and one half years with complete relief of her
previous symptoms.

.

Eserine drops gr.

. helped restore the sight of

I

another patient with chronic glaucoma.

In another case,

vision was impveved by pilocarpine and strychnine injec
tions.
A woman who was losing the sigh� of her left eye
was given pilocarpine and while getting treatment be
crone myopic.

This �yopia seemed to accelerate the im

provement of vision coupled with the pilocarpine.
Following Cross 1 (9) article there were several'
discussions.

In one, Grossman of Liverpool prefered and

got better results with pilocarpine than with eserine.
He also recommended the subconjunctival injectio ns of
sterile sodium chloride which, he noted, would decrease
intraocular pressure. 'The injections can be repeated
often and have given very encouraging re.sults.

(11)

BODY

"It is customary.to divide the various drugs
employed in the treatment of glaucoma into two classes:
(1) miotics, the primary action· of whie� was considered
to be upon the musculature of the iris; and (2) those
having a v.ascular basis.

It is probable, however, that

this division is to some extent artificial, for while
the first class undoubtedly acts to a considerable
extent by the mechanical action of freeing the angle
of the anterior chamber, it is certain they all have a
similar fundamental vascular action which, as in the
case of adrenalin, may be effective even with a coin
cident mydriasis.

In general terms this reaction is a

mild dilatation of the capillary bed resulting in an
acceleration of the circulation thereby relieving
stasis, flushing away waste products, altering the con
d�tions of the fluid traffic of the eye, and promoting
the absorption of acc:mnnlated intraocular fluid,· thus
combatting a state of static edema. 11 (12).
Miotic drugs supplement the p arasympathetic. system
and act in two ways:

(1) by combatting vascular stasis

and edema; and (2) by inducing miosis (12).
Zentmayer (54) believed that if the aqueous humor
. was a dialysate of the blood plasma thro\lgh. the walls

{12)

of the capillaries, and glaucoma results from some dis
turbance of this mechanism, the medical treatment of glau
coma ., especially the newer agents which act upon the capill
aries, should be of considerable value.

If the cause o f

glaucoma was to be sought in structural and mechanical
interference at the angle of the antetior chamber with
the out flow of the intraocular f luids, the main medical dependence in the earlier stages of the disease would
be upon miotics.
In order for mi tics to be efficacious they must
be properly administered.

As the dise se is a chronic

one the action must be maintained for a long period and
for this reason the dose must be gradually increased
and as their action is transient they must be i nstilled
at least three times a day.

A strength suff'icient to

keep the pupil contracted must be constantly maintained •
The weakest of the miotics should be used first, that
is, pilocarpine.

When stronger solutions are used,

several annoying effects are at times noted:

brow-ache,

twitching of the lids ., spastic myopia, irritation of the
conjunctiva and occasi,nally posterior synechia.

Some

of these annoyances may be allayed by incorporating a
weak solution fo cocaine with the miotic.
Zentmayer's (54) regime is to start his patients

(13)

with½ to 2% pilocarpine nitrate two to four times a
If this does not control the tension he reinforced

day.

his treatment with½ to 1% eserine one to three times
a day.

Zentmayer (54) summarized by saying that medical
treatment is indicated in the early stages of the disease;
in patients who acquired the disease late in life and in
patients who have been operated with unfavorable results.
Gradle (18) believed in the use of pilocarpine for
the treatment of simple glaucoma.

He stated that the

eye with simple glaucoma that required the constant use
eserine for the control of tension is an eye that re
quired surgical aid.

or

The effect of pilocarpine may be

enhanced from time to time as required, by the use of
adrenalin, laevoglaucosan, gynergen, or whatever means
the ophthamologist has found most beneficial in the re
duction fo tension.

The strength of pilocarpine and the

frequency of instillation must depend upon the severity
of the condition.

If the disease was in its incipiency,

0.5% pilocarpine two or three times daily would probably
hold the tension curve within normal limits.
In a normal eye, the instillation of pilocarpine
was followed by a slight and temporary rise in tension.
As soon as pupillary contraction was well under way,
the tension sank below the premiotic level, but occasion-
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ally the tension rose instead of' subsiding.

This effect

may be due to impure pilocarpine which contained jaborin,
an iEomeric form of pilocarpine which is a mydriatic.
Eserine promptly relieved the mydriasie.
Of the two more common miotics, pilocarpine is tobe preferred to eserine because:
1. it causes less conjunctival irritation
2. it does not give as much spasm or headache, and
it acts more quietly ·and evenly
3. it maintains the necessary contraction of the
pupil as well as eaerine if properly employed.
When it is a question of producing miosis rapidly, eserine
is the drug to be employed.
Pilocarpine should be used in the weakest doses
to maintain efficient miosis, and sho uld be given before
retiring, .in the morning, and about three P.M.

The timing

is imoortant for rises in pressure occur during sleeping
hours, in the afternoon the vasomotor tone falls and
If
pressure in the eye is in danger of increasing.
'
medical treatment 1s to be tried, miosis must be sustained.
According to Gifford {17), miotics are successful
in most eases in reducing tension to norm.al for a time.
In a certain number of cases this effect might be con
tinued indefinitely.

Tension should be checked at vari-

(15)

ous times of the day and especially early in the morning
before any miotics have been used.

The danger of miotics

is of overconfidence in their effect.

™

The following

two prescriptions were favorites of Gifford (17):
Pilocarpine
Rx

drops

p,ilocarpine nitrate

O.lOgm..

boric acid

o.2ogm.

distilled water to make
Label:

10.00cc.

Drop into eye 1.-5 times daily.

Pilocarpine � salve
Rx
pilocarpine nitrate

o.2gm.

dt,stilled water

1.0cc.

hydrous wool fat

2.0gm.

white petrolatum

7.0gm.

Label:

Apply to affected eye at bedtime.

Pilocarpine probably acted dirctly upon the cells.
It has the advantage o ver eserine in that there were
few systemic effects w hen used in strong concentrations
(even up to 4% for a few instillations).

The prolonged

action, the lack of untoward systemic effects, the
relative freedom of tolerance when used in solutions up
to 2%, and its low cost made it still the most desirable
drug for pro1onged use in chronic simple glaucoma.

It

(16)

was most satisfactorily used for those patients who had
relatively dilated pupils and anterior chambers that
were not too shallow.
Pharmacologically, the primary action of pilocarpine
depended upon the direct chemical stimulation of the
cells in effector organs innervated by the parasympathetic
nervous system. There was a slight vasodilatory action
in conjunction with the above.

It was most effective

When used on a glaucomatous eye having a relatively
dilated pupil a.nd when good miosis is obtained following
its use.

11

Piloearpine was the most effective and gener

ally used drug for chronic simple glaucoma. 11 (34).
In an early case, treatment may be begun with a
0 .. 5% aqueous solution of' pilocarpine.

This may be used

one, two, or three times a day, depending upon the ten
sion.

Since the pressure may rise during the night it

was well to instill the drug just before retiring a.nd
again on arising in the morning.

A 0.5% solution may be

insufficient and in order to determine the strength of
the drug and the number of daily instillations necessary
to control the tension, the patient must be seen at fre
quent intervals and a tension curve plotted.

It was not

enough to make a diagnosis and p rescribe a miotic without
knowing its effect.

It must be remembered that each

case of glaucoma was different and the response to

(17)

The tension was

treatment varied with each individual.

to be taken and a tension curve plotted fo� a few days
until proper dosage could be determined.

Then the patmt

must be seen from time to time in order to check the
intraocu.lar pressure and visual fields.
In order to get full benefit from medication, the
drop was instilled above the upper lim:bus and allowed to
flow across the cornea, then the lids wer<iL-Closed and
gently massaged for 20 or 30 seconds.

With the usual

method of instillation into the lower conjunctival
cul-de-sac, absorption was undependable and unsatis
fa�tory, especially if the lids were opened innnediately.
It was not sufficient to base the treatment of
gl�ucoma on an occasion.al tonometer reading.

The real

criterion as to the efficacy of treatment was vis.ual
field loss; hence, frequent field determinations must
be made.

This was

an

arduous task, but it was a small

price to pay for vision.
There were several unsatisfactory features in the
medical treatment of glaueom.a.

In the first place,

the intraocular pressure may not remain under control
at all times, even though tonometer readings during the
day indicate a tension within normal limits.

If, in

spite of apparent control of tension, there was gradual

(18)

loss of visual field, it was almost a certainty that the
pressu�e waa elevated at night.

Secondly, medication

may ·be improperly administered at home; this was especially
true if the patient instilled the drug himself.

Lastly,

the patient often failed to realize the gravity of the
disease and since there was no pain and the visual
field loss was very gradual, he became careless and used
the medication only occasionally or not at all.
In some early cases and certainly in advanced ones,
the strength of the drug must be increased, another drug
such as doryl substituted or an operation performed.

As

a rule, it was best to use the weakest solution possible.
In some cases 1% epinephrine bitartrate jelly instilled
in the evening one or two times a yrnek would act as an
adjuvant to pilocarpine and keep the tension and visual
loss under control.
Eserine .was a more powerful and more lasting
miotic than was pilocarpine.
for 2 or 3 hours.

It exerted a strong action

Its ,ct'on depended on its acetyl

eholine esterase inhibiting action, together with certain
specific action on parasympathetic effector cells.
caused a moderate dilatation of blood vessels.
able actions of eserine are:

If

Unfavor

it deteriorated rap�dly,

it caused hypersensitivity, and was quite unpleasant to
the patient.

Very few patients can tolerate long con-

(19)

tinued eserine therapv:.
If·the morning rise of tension was high $1.d does
not subside-,

¼%

eserine should be added to reenforce

the action of the other miotics •
. Prostigmine inhibited the action of esterase.

It

was logical to use this or eserine in association with
mecholyl.

Prostigmine was used in a 5% splution.

ProstigtnJine inhibited the action oi' acetyl choline
esterase.

It differed from eserine in that it did not

cause so much unpleasantness to the patient, had a stronger
miotic action and did not deteriorate as quic1dy as ese
rine.

The miosis it produced was usually greater than

that caused _by equivalent concentrations of pilocarpine
and eserine, especially if used in conjunction with its
most marked synergist--mecholyl.
Theoretically, a maximum miosis would be obtained
by using:
1. mecholyl--to stimulate sphincter muscle directly
2. prostigmine--to inhibit esterase. from destroying
both mecholyl and acetylcholine
3. pilocarpine--for its specific action on the
sphincter muscle.
Prostigm.ine, used alone or in conjunction m,,th mecholyl
drops, had shovm great promise in the treatment of chronic
glaucoma.

It seemed to be less irritating than equally

(20)

effective concentrations of eserine.
R ecen�ly another excellent drug, carbam.inoyl choline
chloride ·(doryl), had been made available and in many
cases the tension and visual field loss were controlled
even after pilocarpine had failed.

Doryl was used in

1.5% solution in a mild anti�eptic solution (zephiran◊
which acted as a surf'ace tension reducing agent and
allowed better absorption.

It was used like pilocarpine.

Swan (48) believed that the synthetic choline
derivatives were the most important of the new agents.
However, they were poorly absorbed through the corneal
epithelum.

The effectiveness of instillations of these

drugs could be increased fifty to one-hundred times by
direct massage or by topical anesthesia.
Doryl had been proven to be of great value in the
treatment of glaucoma simplex.

Doryl was consistently

absorbed when 0.03% zephiran was added to the. aqueous
solution.

Absorption was enhanced further PY massage of

the cornea through the lids.

Doryl reduced intraocular

pressure, was a }Ower.f'ul miotic, and produced spasm of
accommadation.

In equal concentration, its action was

not only more pronounced than that of pilocarpine, but
also more prolonged.
Doryl in zephiran solution had been used in the

(21)

treatment or glaucoma simplex for over two yee.rs.

In

many advanced cases, 1.5% doryl in 0.03% zephiran solu
tion administered two or three times daily had controlled
tension and prevented further loss or visual field after
2 to 4% pilocarpine had failed.
No ill effects had been noted from prolonged ad
ministration of doryl and systemic reactic·ns and local
sensitivity had been rare.

However, headache and vary

ing degrees of conjunctival hyperemia frequently followed
the initial instillations of the drug, but were unconnnon
after the first week of treatment.

A c' tange in the

refractive error towards myopia resulted from the inten�e
stimulation of accommodation.
The use of doryl in ophthamology was initiated soon
after the discovery of its properties of causing mi,. sis
and reducillg intraocular pressure.

Velhagen reported

in 1933 that 0.75% o.oryl gave as good

io is as 2%

piloc rpine, but slightly less mlosis than 0.25% eserine.
H_e found only two slight toxic symptoms from the use of
0.75% dor,-1.

Occasionally there developed a passing

hyperemia of the conjunctiva--lasting perhaps twenty
minutes--and one of his female patients suffered a tran
sient headache after administration ot doryl drops.
He found dcryl an effective agent for lowering intra-

(22)

ocular pressure and suggested its use to augment the range
of miotics in the conservative treatment of glaucoma.
In 1937 1 deSantis reported six cases of different
types of glaucoma in which doryl therapy was given.
Early in the treatment of 3 cases of chronic simple
glaucoma, the tension was reduced by doryl.
the duration or active miosis

ana

He studied

reduced tension after

a single application of doryl, and found that miosis lasted
from two to five hours, while reduced tension was pro
longed from 24 to 28 hours after ·a single administration
of 0.75% doryl dropped into the conuunctival sac.

He

attributed the effectiveness of doryl in reducing tension to two factors:

namely, dilation o:t the intra.ocular

vessels, bringing about an increased out flow of intra
ocular fluid, and an inhibition of the secretory activity
of the ciliary body.

Doryl acted by direct stilµulation

of smooth muscles receiving parasympathetic �nnervation
and vasodilatation.

Doryl did not seem to be affected

by choline esterase.

ft

may be said that the effectiveness of doryl in

controlling ocular tension in glaucoma was that doryl
· was better than

2%

pilocappine, about equal to

carpine, and about equal to a mixture of
and 0.5% eserine.

2%

4%

pilo

pilocarpine

(23)

ADVANTAGES OF DORYL
l. Its action in redu.cing intraocular tension was stronger
than 2% pilocarpine.
2. It was valuable as a "rest therapy tr after which
patients were more responsive to the use of the usual
miotics.
3. Doryl was non-irritating.
4. It relieved allergic dermatitis and conjunctivitis
in patients who were ·sensitive to pilo·carpine or eserine.
5. It had specific effect in rare cases for reasons
unlmown in which it controlled ocular tension which had
not been amendable to stronger miotics.

DISADVANTAGES OF DORYL
1. It was mor.e expensive than pilocarpine or eserine.
2. Occasional patients had general discomfort •.
3. There may be transient refractive errors when doryl
was first used, usually mopic.

This effect usually

wore off in a few weeks.
Carbaminoylcholine chloride was one of a group
of synthetic choline derivatives which acted principally
by parasympathetic stimulation.

In chemical structure

it was similar to actyleholine, but its action was more
prolonged, since it was stable in the tissues and
hydrolysis was slow.
Doryl was known'to be a powerful peripheral vaso-

(24)

d11�tor but the only vascular reaction actually observed
in the human eye had been a mild conjunctival hyperemia.
The hypotensive action of doryl on the intraocular
pressure was recognized by Velhagen in 1933.
The chemical and physical properties of doryl ex
plained the lack of corneal permeability to it.

It was

a lipid-insoluble, surface inactive, polar compound.
Therefore, the use of a surface tension reducing agent
in noninjurious concentrations was investigated as a
means of increasJng corneal permeability to the drug.
Zephiran ,:as the detergent which was most efficacious.
There was very little sensitivity to the drug, no
gastro-intestinal disturbances ., headaches occurred occasion
ally for two or three days after starting treatment then
disappeared ., no synechiae were produced as those noted
after prolonged use of eserine.
Comparitive studies of the effects of doryl and of
pilocarpine were made on patients with chronic glaucoma.
The eyes of these patients were divided into two groups
depending on the effectiveness of previous treatment
with pilocarpine nitrate as judged by preservation of
visual fields and lowering of intraocular tension.

In

general, the fourteen eyes in which pilocarpine was.
effective represented early stages of the disease.
visual fields showed only minor-defects, corrected

The
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visual acuity was usually normal and on admission the
tension, with a single exception, was less than 35.mm..Hg.
(Schiotz).

In five eyes, 1% piloearpine nitrate solution

administered three times a day maintained the intra
ocular �ension at a level slightly higher than that
maintained by 0.75% doryl in zephiran solution adminis
tered twice daily, and with the former intradiem varia
tions were greater.

In nine eyes, 2% pilocarpine sol

ution was instilled ·three or four t'imes a day to prevent
loss of visual field.

In two of these eyes, the tension

averaged 28mm. in the morning but there was no loss of
field.

In three grouos of eyes, tension was maintained

at an average of Smm.Hg. lower by the administration of
a doryl-zephiran solution two to three times daily.
The second group included 34 eyes with advanced
glaucoma simplex.

Only 14 of the 34 retained a corrected

visual acuity of 6/9 or better, owing either to visual
field defects involving the central area to lens opacities.
The average tension of this group of eyes was 38mm.Hg.
(Schiotz).
Trea..tment of the second group with 2% pilocarpine
nitrate solution was ineffective.

Tension was not main

tained below 30:mm.Hg. or if it y,as lowered between
20-30mm. there was some loss of visual field after a
trial period of treatment.

Do'ryl solution 1.5% in 0.03%
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zephiran solution maintained the tension in all cases
below 25mm.Hg., arutt there was no further loss qf visual
field over periods up to 20 months.
The reducti n of intraocular pressure with doryl
was not always dependent on miosis.

In three e yes after

an iris inclusion operation in which the sphincter of
the iris i.1:r_s- cut, the tension remained above 33mm.Hg.
post-operatively and 2% pilocarpine nitrate was ineffec
tive.

However; tension ·..a.s maintained below 20mm. by

doryl instilled 2-3 times daily with no loss of visual
field.
Further studies will be required to determine whe
ther doryl loses its efficiency after prolonged use,
as does p1locarpine.

In a few cases it had been possible

to reduce the dose after months of treatment.
Doryl was not effective in controlling the tension
in four patients.

One had only one eye with a small

cornea and a shallow anterior chamber.

In the second

p�tient, swelling of the lens occurred one year after a
trephine operation and was considered to be the cause of
the elevated tension.

There was no explanation for failure

in the other two patients.
Uhler (49} reported that the ocular pharmocology
of furmethide was studied by M�erson and Thau.

Solutions

of 5 to 20% furmethide when instilled into the normal
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human eye were found to produce effects si�1lar to
those of mecholyl.

These effects appeared more promptly .,

were of greater intensity, and of longer duration than
mecholyl.

The pupil began to contract after 2-4 minutes,

reaching maximal miosis within 5-7 minut�s.

A reduction

of intraocular tension of 3-lmnn. was noted after a lapse
of 8-10 minutes ., persisting for 12 to 24 hours.

Al

though a 10% solution was easily tolerated, a 20% s olu
tion induced transient headache and nausea.
The use of furmethide was studied in a group of
twenty patients with chronic glaucoma whose tension
was not controlled by pilocarpine.

The tension of these

patients before furmethide :therapy was begun varied
from 30-40mrn.Hg.

Most of these patients had been using

a 2% solution of pilocarpine from 3-6 times daily previous
to the late rise in tension.

The therapy for four of

these patients was changed to 5% f'urmethide and for the
others to 10% furmethide from 3 to 6 times a day.
On furmethide therapy, 15 patients showed an initial
drop of 5mm. or more in tension.· In 10 patients, the
tension was initially reduced to normal, but 5 of these
patients had a subsequent rise of tension after a period
or 2 to 9 months, with normal tension and no rurther loss
of fie_ld.
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No systemic or local reactions to fu.rmethide were
noted over prolonged periods of. administration.

Occasion

ally, the patients complained of morning headaches or
transient blurring of vision immediately,after instilla
tion of the drug.
Mecholyl was similar in action of adrenalin; .it caused
an active hyperemia of the ocular vaseular bed which
carried away accumulated and relatively stagnant 1J.lood
in the smaller blood vessels.

It was without the danger

ous mydriatic action of adrenalin and has the advant�ge
of being a strong miotic.
Mecholyl, 2�% solution was effective in contracting
the pupil.
Lottrup and Andersen (35) recommended the use or
adrenalin in the treatment of glaucoma simplex.

They

said that the main reason for the adrenalin ·treatments
not gaining popularity was the fear of a secondary rise
in intraocular pressure.

Th�ethod that was presented

here was more practical, less dangerous, and was easy
to perform according to Lottrup and Andersen (35).

A

minute tampon of cotton moistened with a 1-1000 solution
of adrenalin was placed between the globe and lower lid
where it was left 1-15 minutes.

The tampon contained only

1/3 to½ drop when put into the eye and tears washed away
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part of the.adrenalin.

By leaving the tampon in for 15

minutes, Lottrup thought it poss�ble to get as big an
action-as with the usual subconjunctival injection of
¼-1/3cm.

Lottrup got more oval dilatation of the pupil

and in this way the dang er of a rise in pressure should
be limited.

Pilocarpine was instiiled both be.fore and

after treatment.
Ham.burger Ei.nd Vannas had shown that there was a
dilatation of the other eye followed by a decrease of
pressure.

Hamburger had also shown that the t�ea ted eye

was sensibilized and again made influenzable for the action
of miotics, an effect which lasted for days and weeks and
perhaps even-months.

The patients could now continue

their treatment at home with pilocarpine instillations.

As a rule every new treatment gave a still greater
decrease of intraocular pressure.

Each ti111e when the

pressure rose again, a new adrenalin tampon was applied.
In several cases, pressure had been kept down for as long
as seven years.
A review of the voluminous literature on epinephrine
and the glaucosans indicates that their greatest field
of usefulness was in the treatment of glaucoma simplex.
Sometimes when the tension in the glaucamatous eye cannot
be maintained at a sufficiently low level with the cus
tomary miotics, this may be accomplished with epinephrine.
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In other instances, the miotics become ineffective after
a short period, and the tension rose to a d angerous degree
in spite of vigorous use of physostigm.ine or pilocarpine.
By_changing to epinephrine, one could generally arrest
the progress and could cause the pressure to return more
ne··rly to normal.

When the application of the miotic

preparations was resumed, it would be found that they
had regained their former effectiveness.

The tension

occasionally could be controlled over long pe�iods of
time by epinephrine, used alone or in conjunction with
physostigmine or pilocarpine.

This was of particular

imnortance in the case of old patients unsuitable for
operation, in whom it V'ias often possible through the use
of epinephrine to ayert blindness for their few remain
ing years.
Laevoglaucosan either acted directly on the muscle
cells of the dilator ::mscle of the pu •il or ·on the �-.,m
pathetic cells ·wh:.ch lay within it.
Erdmann, in 1914, was the first to use epinephrine
subconjunctivally in :··1aucoma, having observed a tono
metrically notably protracted diminution of tension after
its applica ion.

Since he saw an occasional elevation

of tension, he recommended its use for chronic glaucoma
only.

Gifford (17) suggested using eserine before and

after the instillation of glaukosan to prevent rises of

(31)

tension.
The primary action of laevoglaueosan and �pinephrine
bitartrate,. that of causing a fairly rapid fall in ten
sion, in cases of chronic glaucoma was due to anemia
induced in the vascular bed.

The prolonged lowering of

the tension was probably due to a temporarily improved
metabolism of the eye.
Laevoglaucosan: was a valuable adjunct to miotics.
It was not universally successful in reducing tension.
It produced the foJ.lowing effects:
l. intense ischemia of the conjunctiva, with
bloodless islets appearing in the cheek, lid,
and temple,
2. widening of the'palpebral aperture,
3. regular and wide dilatat�on of the pupil and
4. a diminution of intraocular tension.
In glaucoma simplex, glaucosa� was capable in
cases where eserine and piloca.rpine remained ineffective
of bringing about an appreciable reduction of pres�ure
and t·o sensitize the eye again in such a way that mio
tics again became effective.

A trial should be made with

glaucosan in suitable casps where miotics failed prior
to operative interventions.

One drop of glaucosan was

instilled into the eserined eye.

The pupil was to be en-
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larged only half wide.

After� hour, apply miotics in

intervals of 15-20 minutes, the pupil to became narrow
again and to remain so.

All this to be done in the fore

noon, with observation to follow.

If the pressure drops

adequately, it may be left at one drop, otherwise two
drops should be tried, repeating 2 to 3 times an hour.
Although it· cannot be determined definitely which
glaucoma simplex eyes will react by increased pressure,
nevertheless, it may be maintained from experience that
it was primarily eyes of a tension of 40mm. and above
which had such a propensity.
Gradle's method of reducing intraocular pressure
was used by Z entm.ayer (54):

anesthetize the eye with

butyn or holocaine and then tuck a small piece of cotton
saturated with three or four drops of adrenalin up under
the upper lid into the cul-de-sac and allow it to �em.9:in
four or five minutes.

In most cases of chronic simple

glaucoma a fall of tension of from five to twenty mm. Hg.
occurred.
Adrenalin {levo-r_otatory) and glaukosan (dextro

rotatory a�renalin which. had no tendency to elevate blood
pressure) and benzedrine probably reduced the intra
ocular pressure only when used in sufficiently concen
trated solutions that the secondary phase of vasodilata�
tion was very marked and resulted in the flushing out
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or substances such as choline-esterase.
Epinephrine had had �eatest value as an adjunct
With patients

to pilocarpine therapy of chronic glaucoma .

for whom surgery was inadvisable and miotics were only
partially effective, the administration of epinephrine
once or twice weekly m�.ght have controlled the tension
and prevented loss of visual field.
· In chronic glaucoma, a significant rise in intra
ocular pressure rarely followed the administration of
epinephrine and then only in those cases in which there
were advanced changes in the anterior segment of the eye.
These changes included multiple anterior synechiae, ex
tremely sha llow anterior chambers, and degenerative pro
cesses in the iris.
Adler (1) believed that all treatment of chronic

glaucoma, medical as ·w�ll as sur�ical, should. be directed
at r_elieving the chief symptom of the disease, that is, an
increas� of intraocular pressure.

The intraocular

pressure can be reduced. by the following means:
1. ma.king the blood hypertonic, so that fluid is
withdrawn from the interior of the eye into the intra
ocular blood vessels.
2. contracting the vascular bed of the choroid, so
I

that the volume of the intraocular contents was reduced.
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3. miotics.
By contracting the pupil, the outflow of aqueous was
enhanced from the anterior chamber.

Miotics may have an

additional action but until we have more evidence, we may
consider that they lower intraocular pre.s sure chiefly by
this means •.
SUBSTANC ES WHICH lvIAKE THE BLOOD HYPERTONIC
i. Sod�um Chloride--30%
This reduced tension but was diffusible through the
capilla ry walls and was followed by a rise in preg;...
ure to former reading or above.
2. Glucose--50%
This was less diffusible than salt but eventually
passed back through the ocular capillaries and the
fluid went back tnto the eye again with resulting
rise in tension.
3. Sucrose--25%
This -sugar did not diffuse into the aqueous and was
very slowly eliminated by the kidneys.

There was

a marke4 reduction in tension in 4 to 6 hours.
The effect gradually wore off and the tension slowly
rose to its previous level.

It was contraindicated

in patients with renal damage.
4. Sorbitol--50%
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Lindberg had found that. sorbitol did not effect
the kidneys.

It could be used in diabetics.

The

tension reduction reached a maximum in 12-24 hour�
it gradually wore off and tension rose to its pre
vious level.
VASOCONSTRICTOR SUBSTANCES
Any substance which would contract the blood vessels

in an organ would reduce the tissue tension as th� volume
of blood in the organ was diminished.
1. Adrenalin
It was not absorbed from the conjunctiva, so it
must be given as packs under the upper lids or in
jected sub-conjunctivally.

It caused a remarkable

drop in tension in from 12-24 hours.
simultaneous mydriasis.

It caused a

Its tension reducing action

was due to constriction of the vascular bed or to
the marked vasodilatation which followed the constrict
or activity.
2. Ergotamine
This was a preparation of ergot that was supposed
to decrease the permeability of the bl�pd vessels.
Ergotamine tartrate (gynergen) given by mouth is
of value'as an adjuvant and may be substituted
temporarily for local treatment when folliculosis
develops.
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3. Neosynephrin
The author said it reduced the tension in some
cases.

It was a mydr1atic.

Post (41) has noted that neosynephrin had the pro
perties of the other epinephrines.

It produced mydrias�s

as quickly, as fully, and as safely as any mydriatic.
It was non-irritating and stable.
the glaucoma.tous eye.

It reduced tensi·on in

It m�ght elevate the tension as

will other epinephrines bµt in a very limited manner.
Elevation of tension should not eccur if some miosis is
maintained with eserine.
The possession of an additional means of lowering
intra.ocular pressure when methods ordinarily used either.
are contraindicated or are inadequate is a valuable asset.
Hypertonic solutions in the control of ocular hyper
tension had their gre.'.:ites_t usefulness in those cases
in which the tension remained high in spite of the admin
istration of the strongest m1otics.

Osmotic therapy had

the disadvantages of o verburdening the heart with in
creased blood volume and injury to the median nerve might
result.
For osmotic therapy in ophthamology, a substance
wa� -wanted that was relatively non-diffusible, non-toxic .,
eff'ective in moderate quantities and usable in persons
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with diabetes.

Sorbitol most nearly satisfied these re

quirements.
Sorbitol caused maximum lowering of the intrao9ular
pressure in from 12-24 hours.

Then the tension gradually

rose a.nd reached a level approximately the original
value.

In some _patients, repeated injections of sorbitol

would produce an effect where single injections failed
to produce a change.

100cc. of 50% solution of sorbitol

I.V. and repeated in 24 hours if necessary, would nearly
always reduce intra.ocular pressure when it was greatly
increased and not controiied by the use of miotics alone.
Woods, in studying eleven patients with chronic
glaucoma in which he used extracts or adrenal cortex
hormone found that the administration of adrenal cortex
ext·fct had no effect on intravcular tension., As far
as could be ascertained, adrenal cortex extract is
totally inert in pa�i�nts with chronic simple glaucoma.
Ergot depressed the end organs of the s·ympathetic

nervous system.

Its use in chromic glaucoma was based

on the assumption that increased tension was due to hyper
activitY.

or .the

central nervous system and th at ergot

would lessen the penneability of the vessel walls.

The.

form employed was ergots.mine which was sold under the trade
name of gynergen.

This might be used as an injection of

l/250gr. or orally l/60gr.
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Thiel, Hein, et al, reported that tension might be

.

kept do:ffi to normal in simple glaucoma over long periods

of time by oral dosage of two or three tablets, 2 to 3
times a day.

Gynergen seemed to b e a valuable adjunct

to other treatments.

It was absolutely harmless to �he.

eye so far as was known and could readily be used in
conjunction with pilocarp1ne, eserine, etc.

The only

known contraindicaUon waa_l;Iypertensio'.Q..
Lillie (34) of Philadelphia, thought that there
were two distinct schools of thought regarding treatment
of glaucoma simplex.

Those in the first school of thought

instituted a regime consisting of the use of miotics
and other supportive treatment, so regulated for each
individual eye that the intraocular pressure was held
wi·thin normal limits •. The patient should be kept under
ocservation often enough to know that the therapeutic
result was .satisfactory.
The second school of thought considered that all
cases treated :with miotics or other supportive treatment
sooner or later have to undergo surgical intervention
and advocated e�rly operation, to be followed by miotics
post-operatively if necessary.
The 0phthamologist cannot carry out treatment ade
quately without the patient's ful+ cooperation.

The patient

can be of real aid to the eye physician and of even
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greater value to himselt' wgile the pr9per therapeutic
regime was being instituted by observing the following
precautions:
(l)

Follow instructions carefully concerning
treatment at home.

Use drops exactly as

prescribed.
(2)

Avoid dark rooms and ttmovies".

I,;f patient

must go to movies, use dropa before and
after.
(3)

Do not get excited or angry as emotional up�
sets will bulge the eyes, dilate the pupils,
and increase intraocular. pressure.

(4)

Do not wear a tight collar as venous com
pression increases intraocu.lar pressure.

(5)

Do not drink coffee.

Coffee increases

(6)

Stay outdoors, especially on bright days,

intraocular pressure in glaucomat6us eyes.
as miotic pupi.ls help decrease.intraocular
pressure.

(7)

Keep bowels regular.

Saline cathartics

produce dehydration which aids in decreasing
intraocular pressure.
The patient should be informed that chronic glau
coma is not curable but that blindness from glaucoma
is preventable in a large number of cases.

It can
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be explained that it is synonomoua with insulin and diet
not curing diabetes� but con�rolling it only.

With this

understanding between the ophthamologist and the patient
better cooperation is obtained and maintained.over the
long period of time necessary for the proper manage
ment of chronic glaucoma.

(41)

SUMMARY
The treatment of chronic simple glaucoma is very
unsatisfactory as yet, because the etiology is still
unlmown and no disease can be successfully combatted un
less the causative agent is first determined.

The

treatm�nt of glaucoma simplex is said to be quite success
ful when the intraocular tension is maintained within
normal limits and the visual fields are not decreasing.
The general health of the patient must be considered
as well as his habits and temperament to successtully
inhibit the disease.
There is a remarkable diversity of opinions among
ophthamologists as to what mode of treatment is best in
chronic glaucoma.
The early ophthamologists experimented with every
pharmaceutical preparat�on they could obtain, both
loca1ly and systemically.

In the latter half of the

19th century, piloearpine was introduced which was a
distinct advancement in the therapy of chronic glaucoma..
Most 01'11thamologists agree that ½-2% pilocarpine
nitrate used several times a day is the best treatment
for chronic glaucoma.

However, there must be frequent

checks on the intraocular pressure and the visual fielcs.
If there is the slightest suspicion that pilocarpine is
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not effective, another �t�onger �ug should be tried.
Doryl is such a miotic and results on the use of th.is
drug in patients with chronic glaucoma are encouraging.
Doryl is UBually used in a o.75% solution instilled two
or three times a day as necessary.

After a few weeks

of doryl therapy, pilocarpine can be again resorted to
with more efficacy than formerly.
Eserine is to be avoided for continued treatment of
chronic glaucoma unless used in conjunction with another
drug and in very weak concentr�tions,
always .suffice.

¼%

will nearly

Eserine is a stronger miotic than pilo

carpine, hoever, its effect lasts only two or three
hours and it is much more irritable to the patient.
The use of adrenalin and other hyperemic drugs has
its followers but popular opinion and experimental eY-idence
show that the disadvantages overbalance the advantages
�in

this form of therapeusis.

Adrenalin is indicated in

patients for whom surgery is inadvisable and miotics are
noc effective.
Systemic therapy is a valuable adjunct to local measures.
If the tension continues to increase and the visual

fields gradually are being lost, a more radical form of

interventi\)n must be sought, that is, sur�er,.

Operative

intervention oftentimes has to be followed by further

medical treatment.
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CONCLUSIONS
In an early case of glaucoma simplex, that is ., one
in which the tension was only moderately elevated and
visual field loss was slight ., an attempt was made to lower
t ?e increased intraocular pressure with drugs.

Usually

the· tension was not greatly elevated and often the response
to miotics was satisfactory, at least for a ·time.

In

some cases one would find the typical early field defects
of glaucoma, but the intraocula.r pressure was little if
at all ., above normal.

Then one must make provocative

tests in an attempt to �stablish a diagnosis.

In such

early cases, treatment may be instituted with a weak
sclution of one of several drugs, instilled from one to
three times daily.

Most of these drugs ., notably pilocarpine,

carbaminoylcholine chloride ., acetyl-beta-methylcholine
chloride, prostigmine ., and furmethide stimulated the
paras-ympathetics.

Pilocarpine nitrate or hydrochl�ride

was the olde[:t and best known of the miotics ., however,

some of the newer drugs, especially •�doryl 1], o!'ten seemed

to be more effective.

It was believed that neither meohol7l

nor prostigmine would do any more for a case of glaucoma
than pilocarpine.

Eserine seemed to have no place in

the treatment of glaucoma simplex since, when used over
prolonged periods of time, it was often irritating and
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gave rise to folliculos1s of the conjunctiva and even t o
iris irritation with the formation of synechiae.

Also

any case which required eserine usually did bette;r on
surgical treatment.
Some cases of glaucoma simplex failed to respond
to medication and one must resort to surgery.

If the

disease progressed in spite of medical treatment, it
·was well to operate before there was much contraction
of the visual fields.

(1)
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